Webinars starting with R

In today’s world of rapidly evolving analytics, legacy reporting and BI platforms hinder a company from using analytics to its full potential due to the associated technology barriers, limited capabilities and long development cycles. The promise of competitive differentiation is driving commercial organizations to invest in AI/ML powered analytics. Secondly, AI-powered insights coupled with enhanced user experience and productivity allow businesses to engage customers more effectively. As a result, there is an increase in AI adoption for meaningful business insights that are easier to access, faster and cost-effective compared to the legacy solutions.

Join us in this interactive panel discussion to hear from industry stalwarts how AI/ML/NLQ powered analytics enable accelerated insights and improve customer engagement for business success.

Key discussion points:

• Business impact of democratized access to data insights and customer engagement
• Role of AI/ML in the evolution of analytics: data integration at scale, expedited insights cycle and improved customer engagement
• Key factors to consider for successfully utilizing AI/ML: richer data sources, 360 degree view and domain focus
• Top themes for life sciences enterprises and commercial organizations for deploying AI/ML

Moderator:

• Richard Clements, VP Marketing, WhizAI

Panelists:

• Dharmesh Thakkar, Sr. Director - Commercial Operations, Janssen Pharmaceuticals
• Stuart McGuigan, Senior Advisor, McKinsey & Co (former CIO Johnson and Johnson)
• Manesh Naidu, Consultant

The COVID-19 crisis has upended 2020 commercial priorities and budgets, leaving many pharma organizations searching for a customer engagement strategy that can operate in the New Normal. Pharma organizations need to succeed with a new commercial model by improving planning, coordination, and resource optimization in a way that ensures sales, marketing, and customer excellence are truly recalibrated to the current situation and contribute significantly to profits. While sales rep enablement for remote or virtual meetings is important, winning in the New Normal would require deep content, technology, data, and analytics capabilities across personal and digital interactions.

In this webinar, we will be discussing about how the pharma sales and marketing landscape is evolving and the critical strategic planning and executional capabilities required for next-gen commercial operations. We will also share a new unified approach towards driving sales and marketing analytics consisting of the following key components: Customer Strategy, Channel and Content Strategy, Unified Marketing Mix, Digital Call Planning and Sequencing, Deployment and Execution, and Measurement Planning.

Presenters:

• Krishnan Raman, Director, Indegene
• Debasish Das, Sr. Manager, Indegene
• Tarun Shukla, Engagement Manager, Indegene

While many organizations are experimenting with machine learning in various corners of the organization, many are asking how to create something more robust. “How do we move from small, one-off experiments to something more repeatable and scalable?”. In this webinar, we’ll present a point-of-view on the critical elements and capabilities your organization will need to get there.

Presenters:

• Phil Daniels, VP, Data Ops and Analytics Platforms, Indegene